ESM1 and thyroid gland carcinoma: Our study propels ESM1 to the forefront of the discussion on thyroid cancer treatment, suggesting that monitoring ESM1 expression could serve not only as a means of gauging disease progression but also as a guide for customizing patient-specific treatment plans.